Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

INCOME TAX (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
INCOME TAX (Details Narrative) - USD ($)	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Provision for income tax	$ 293,000	$ 56,000	$ 80,000	$ 159,000
Unrecognized tax benefits	$ 0	$ 0	$ 0	$ 0

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.